NCT03770117View on ClinicalTrials.gov

Study of the Effect of Prehabilitation on Markers of Sarcopenia in Patients Undergoing Pancreatoduodenectomy for Malignant Disease

CompletedOBSERVATIONAL
Enrollment

113

Participants

Timeline

Start Date

October 4, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2019

Conditions
Pancreatic Ductal Adenocarcinoma
Interventions
PROCEDURE

Prehabilitation

Participants who underwent Prehabilitation will have their CT scans analysed.

PROCEDURE

Standard Procedure

Patients who underwent a panctratoduodenectomy and did not receive any Prehabilitation will have their CT scans analysed and compared.

Trial Locations (1)

M13 9WL

Manchester University NHS Foundation Trust, Manchester

All Listed Sponsors
lead

Manchester University NHS Foundation Trust

OTHER_GOV

NCT03770117 - Study of the Effect of Prehabilitation on Markers of Sarcopenia in Patients Undergoing Pancreatoduodenectomy for Malignant Disease | Biotech Hunter | Biotech Hunter